Compare RANI & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | DLNG |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.7M | 139.0M |
| IPO Year | 2021 | 2013 |
| Metric | RANI | DLNG |
|---|---|---|
| Price | $1.24 | $3.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 124.1K |
| Earning Date | 03-30-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 5.26% |
| EPS Growth | N/A | ★ 30.14 |
| EPS | N/A | ★ 1.29 |
| Revenue | $1,200,000.00 | ★ $158,275,000.00 |
| Revenue This Year | $414.59 | N/A |
| Revenue Next Year | $30.15 | $0.37 |
| P/E Ratio | ★ N/A | $2.95 |
| Revenue Growth | N/A | ★ 4.34 |
| 52 Week Low | $0.39 | $3.18 |
| 52 Week High | $3.87 | $4.40 |
| Indicator | RANI | DLNG |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 54.04 |
| Support Level | $1.07 | $3.70 |
| Resistance Level | $1.42 | $4.27 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 49.28 | 43.02 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.